Abstract:Tumor-associated macrophages (TAMs) are important components of the tumor microenvironment (TME) and are characterized by plasticity and heterogeneity. This heterogeneity reflects the ability of macrophages to respond to environmental stimuli, leading to their differentiation from proinflammatory (M1-like) to anti-inflammatory (M2-like) phenotypes [1]. Specific subsets of TAMs mediate different processes, such as orchestrating angiogenesis, extracellular matrix remodeling, cancer cell proliferation, metastasis, and immunosuppression, by providing malignant cells with trophic and nutrient support, which is mostly related to poorer clinical outcomes [2, 3]. Moreover, TAMs mediate tumor phagocytosis and promote antitumor immunity, leading to better clinical outcomes. Thus, how to regulate TAMs to reverse their transition from the M2-like phenotype to the M1-like phenotype is an urgent scientific issue. Serine metabolism is known to regulate immune cell functions, but how it specifically regulates macrophage polarization remains largely unclear [4]. In a recent study, Cai et al. [5] reported that phosphoglycerate dehydrogenase (PHGDH)-mediated serine biosynthesis promoted α-ketoglutarate (α-KG) production, activated mammalian target of rapamycin C1 (mTORC1) signaling and contributed to the maintenance of an M2-like macrophage phenotype in the TME. Cai et al. [5] used genetic approaches to ablate the Phgdh gene in macrophages and discovered that PHGDH was required for the immunosuppressive activation of the Th2 cytokine interleukin (IL)-4. Deletion of Phgdh augmented the development of the LPS-induced inflammatory phenotype. In a syngeneic mouse model of mesothelioma, PHGDH expression was strongly increased in TAMs, and conditional deletion of Phgdh suppressed TAM infiltration and delayed tumor growth. Additionally, the PHGDH-mediated serine synthesis pathway plays a crucial role in regulating the conversion of glutamate to α-KG, which is necessary for mTORC signaling activation and sustains immunosuppressive M2 activation and TAM expansion. These findings provide a strong basis for further exploration of PHGDH as a potential target to counteract TAM-mediated immunosuppression and inhibit tumor progression.

Myeloid Deletion of Phosphoinositide-Dependent Kinase-1 Enhances NK Cell-Mediated Antitumor Immunity by Mediating Macrophage Polarization.

Mir-182 Targeting Reprograms Tumor-Associated Macrophages and Limits Breast Cancer Progression

Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma

miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy

Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling

Targeting macrophage metabolism to enhance tumor immunotherapy

PDK1 Promotes Tumor Growth and Metastasis in a Spontaneous Breast Cancer Model

MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype

MDK promotes M2 macrophage polarization to remodel the tumour microenvironment in clear cell renal cell carcinoma

LincRNA-p21 Knockdown Reversed Tumor-Associated Macrophages Function by Promoting MDM2 to Antagonize* P53 Activation and Alleviate Breast Cancer Development

Defects in Macrophage Reprogramming in Cancer Therapy: the Negative Impact of PD-L1/PD-1

MED1 induces M2 polarization of tumor-associated macrophages to aggravate breast cancer

Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis.

p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition

M2-Like Tumor-Associated Macrophage-Targeted Codelivery of STAT6 Inhibitor and IKKβ Sirna Induces M2-to-M1 Repolarization for Cancer Immunotherapy with Low Immune Side Effects

Breast cancer cells promote CD169<SUP>+</SUP> macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages

Increased Infiltration of Macrophages to Radioresistant Lung Cancer Cells Contributes to the Development of the Additional Resistance of Tumor Cells to the Cytotoxic Effects of NK Cells.

Macrophage proliferation machinery leads to PDAC progression, but susceptibility to innate immunotherapy

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Critical role of CD206+ macrophages in promoting a cDC1-NK-CD8 T cell anti-tumor immune axis

Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression